This Week’s Biotech Highlights
As everyone starts the year off with resolutions for self-improvement, I prefer to deflect by analyzing others’ flaws. This week provided several targets for deflection in the biotech world:
- New federal-level initiatives in the U.S. and China and state-level initiatives in North Carolina, Missouri, Arizona and Indiana (not to mention Québec’s new Biopharmaceutical Strategy) mean that Ontario has to up the ante if it wants to improve its ability to grow and attract top biotech talent.
- Policy makers and commenters need to look farther into the future to effectively regulate the coming revolution in reproductive genomics — “designer babies”


